Insulin Resistance By Age 30 Quite Telling Of Future Heart Health
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

A prospective CARDIA cohort analysis found that insulin resistance at ages 18 to 30 was associated with a higher risk of atherosclerotic cardiovascular disease later in life. Midlife metabolic syndrome accounted for an estimated 63.4% of the association, but the observational study does not show that insulin resistance directly causes heart disease.

A long-term analysis of 3,622 CARDIA participants found that insulin resistance in young adulthood was associated with a higher risk of atherosclerotic cardiovascular disease (ASCVD) later in life. The association was partly linked to metabolic syndrome by midlife, suggesting that cardiometabolic changes may accumulate over decades; the observational findings do not establish cause and effect.

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

Participants entered the study in 1985-1986 at ages 18 to 30, with a mean age of 25 years. The analysis included people who remained free of ASCVD through year 20, when they were ages 38 to 50. About one in four had insulin resistance at the study baseline. Researchers then tracked ASCVD events through year 35, when participants were ages 53 to 65.

Compared with participants without insulin resistance at baseline, those with it had a higher risk of later ASCVD events: risk ratio 1.50 (95% confidence interval 1.13-2.01). The researchers reported a median follow-up of 14 years after year 20. During that period, 3.9% of participants experienced an ASCVD event.

The researchers estimated that metabolic syndrome at year 20 mediated 63.4% of the association between early insulin resistance and later ASCVD. This is a statistical estimate of how the relationship may operate, not proof that metabolic syndrome caused the later events. The study was led by Chuyue Wu of the UCLA Fielding School of Public Health and published in JACC: Advances, according to the report.

At a glance
reportWhen: Study reported November 20, 2026; parti…
The developmentA CARDIA cohort analysis published in JACC: Advances found an association between insulin resistance in young adulthood and later ASCVD events, with much of the association linked to midlife metabolic syndrome.

Why Early Risk Signals Matter

The findings point to young adulthood as a possible period for noticing cardiometabolic risk before several abnormalities cluster together. Insulin resistance can precede changes in waist size, blood pressure, blood sugar and blood lipids, which are among the factors used to identify metabolic syndrome. The study suggests that the pattern over time may matter, not just whether a person meets a threshold at one examination.

That does not mean the research establishes a new screening test or changes clinical guidance. Fasting insulin is not routinely measured in clinical practice, and the authors said more research is needed to determine whether the measure used in this analysis improves risk prediction beyond standard clinical factors. The practical relevance is the potential value of monitoring known risk factors over time, rather than treating this result as an individual prediction of future heart disease.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

How CARDIA Measured Risk

The CARDIA study is a multicenter, population-based prospective cohort that enrolled young adults in 1985-1986. The analysis included participants who were still free of ASCVD at year 20; the group was 45% men and 47% Black. Because the analysis excluded people who had developed ASCVD by that point, its results describe this selected group rather than every participant originally enrolled.

Researchers assessed insulin resistance using HOMA-IR, a calculation based on fasting insulin and glucose. A value at or above the study’s 75th percentile—at least 2.67—met the study definition. The authors cautioned that this indirect measure may not correspond exactly to the hyperinsulinemic-euglycemic clamp, described as the gold-standard method. Metabolic syndrome was defined by meeting at least three criteria involving waist circumference, triglycerides, HDL cholesterol, blood pressure or treatment, and fasting glucose or treatment.

“Insulin resistance in young adulthood may signal an adverse cardiovascular-kidney-metabolic trajectory before conventional cardiometabolic risk factors become fully established.”

— Chuyue Wu and colleagues, study authors

Limits of the Risk Estimate

The study was observational, so residual confounding may help explain the association. It cannot establish that insulin resistance itself caused later ASCVD or that preventing it would reduce events. The researchers also did not account for changes in metabolic syndrome status or its individual components before or after the year-20 assessment.

The insulin-resistance definition relied on a fasting calculation rather than the clamp method, and the analysis does not establish how well HOMA-IR predicts risk beyond routinely collected measurements. The results also apply to the participants included in this analysis, who were free of ASCVD through year 20. Whether the findings generalize to other populations or support changes in screening and treatment remains unclear.

Research Needed Before Practice Changes

The authors called for studies testing whether HOMA-IR adds useful prediction beyond established clinical factors and for practical ways to identify insulin resistance when fasting insulin is not available. They also said research should test whether preventing or delaying progression to metabolic syndrome reduces subsequent ASCVD risk. Until those questions are answered, the study supports further investigation rather than a new clinical rule.

For now, the findings add long-term cohort evidence to discussion of early cardiometabolic risk. Whether clinicians should change screening practices, and which interventions would alter the observed trajectory, will depend on further research and clinical guidance.

Key Questions

What did the CARDIA analysis find?

It found that participants with insulin resistance at ages 18 to 30 had a higher risk of ASCVD events later in life than participants without it. The reported risk ratio was 1.50, with a 95% confidence interval of 1.13-2.01.

Does the study prove insulin resistance causes heart disease?

No. This was an observational analysis, which can identify associations but cannot establish that insulin resistance caused the later events. Other factors may contribute.

How did researchers define insulin resistance?

They used HOMA-IR, a calculation based on fasting insulin and glucose. A score of 2.67 or higher—the study group’s 75th percentile—met the definition. The authors said this indirect measure may not match the clamp method exactly.

What role did metabolic syndrome play?

The researchers estimated that metabolic syndrome at the year-20 assessment accounted for 63.4% of the association between early insulin resistance and later ASCVD. That estimate does not prove metabolic syndrome caused the subsequent events.

Does this mean young adults should get a new insulin test?

The study does not establish a new testing recommendation. The authors said further research is needed to determine whether HOMA-IR adds predictive value beyond routinely measured clinical factors; fasting insulin is not routinely measured in clinical practice.

Source: medpagetoday.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Long Covid May Physically Damage The Nerves That Control The Stomach

Research suggests Long Covid can cause physical damage to nerves that regulate stomach functions, raising concerns about persistent gastrointestinal symptoms.

Cyclospora Parasite Outbreak

Over 1,000 cases of cyclospora infection have been confirmed across the US, prompting health alerts and ongoing investigations into the outbreak’s source.

What’s More Important In Retirement – What You Want Or What You Need?

A Sixty and Me essay asks retirees to weigh health and financial needs alongside interests, connection and personal goals.

What I Tell AI, What I Keep To Myself, And How It Watches My Back

A Sixty and Me contributor describes using ChatGPT to find care resources while withholding identifying details—and urges readers to verify AI’s answers.